What does ANTWERPS DRUG INTERVENTIE CENTRUM do?

ANTWERPS DRUG INTERVENTIE CENTRUM is a hospital in Antwerpen. Non-profit, started on 7 October 1985, 1 establishment.

What is the address of ANTWERPS DRUG INTERVENTIE CENTRUM?

The registered office of ANTWERPS DRUG INTERVENTIE CENTRUM is located at Venusstraat 11, 2000 Antwerpen.

Is ANTWERPS DRUG INTERVENTIE CENTRUM still active?

Yes. According to the CBE (29 October 2026) ANTWERPS DRUG INTERVENTIE CENTRUM is active, legal situation “Normale toestand”, started on 7 October 1985.

Is ANTWERPS DRUG INTERVENTIE CENTRUM registered on Peppol?

Yes, ANTWERPS DRUG INTERVENTIE CENTRUM is registered on the Peppol network with ID 0208:0431752146.

What is the enterprise number of ANTWERPS DRUG INTERVENTIE CENTRUM?

The enterprise number of ANTWERPS DRUG INTERVENTIE CENTRUM is BE0431752146.

When was ANTWERPS DRUG INTERVENTIE CENTRUM founded?

ANTWERPS DRUG INTERVENTIE CENTRUM was founded on 7 October 1985.

Is ANTWERPS DRUG INTERVENTIE CENTRUM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 October 1985; 5 annual accounts filed, latest fiscal year 2025; 5 directors known from the annual account.

How much profit did ANTWERPS DRUG INTERVENTIE CENTRUM make in 2025?

ANTWERPS DRUG INTERVENTIE CENTRUM posted a profit after taxes of € 249,972 in financial year 2025.

What is the revenue of ANTWERPS DRUG INTERVENTIE CENTRUM?

As a small company, ANTWERPS DRUG INTERVENTIE CENTRUM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 4,960,704.

How much does an employee at ANTWERPS DRUG INTERVENTIE CENTRUM earn?

The average wage cost per full-time employee at ANTWERPS DRUG INTERVENTIE CENTRUM was € 88,400 in 2025: staff costs of € 4.3 million for 48.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does ANTWERPS DRUG INTERVENTIE CENTRUM have?

According to the 2025 annual accounts, ANTWERPS DRUG INTERVENTIE CENTRUM has 48.5 full-time equivalents (FTE).

ANTWERPS DRUG INTERVENTIE CENTRUM (Non-profit)

Q: Who are the directors of ANTWERPS DRUG INTERVENTIE CENTRUM?

According to the 2025 annual accounts, the directors of ANTWERPS DRUG INTERVENTIE CENTRUM are: Alain Florquin, Stefaan Voet, Jimmy Schevernels, Jan De Maeyer, Robby Cardinas.

Dossier ANTWERPS DRUG INTERVENTIE CENTRUM, printed on 29 October 2026 from databakkes.be/en/0431752146/antwerps-drug-interventie-centrum. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

ANTWERPS DRUG INTERVENTIE CENTRUM from Antwerpen, company number BE0431752146, closed financial year 2025 with a result of € 249,972 after tax. For that financial year ANTWERPS DRUG INTERVENTIE CENTRUM recorded a gross margin of € 5 million and equity of € 3.9 million. Compared with financial year 2024, the result moved from € 168,214 to € 249,972. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What it is worth Growing

€ 3.9 million

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 249,972

▲ 49% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2 million

▲ 33% vs 2024

Cash and bank balances on the last day of the fiscal year.

People and assets in 2025

Full-time equivalents

48.5

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 4.3 million

▲ 2% vs 2024

€ 88,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 19,435

▼ 8% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 25 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 2.9 million

▼ 4% vs 2024

€ 114,812 is repaid this year. At this pace the long-term loan is gone in ≈ 25 years.

Owed to suppliers

€ 50,559

▲ 39% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 717,421

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 4,374,247 Gross margin 2022: € 4,374,247 First fiscal year in the series	€ 4,552,354 Gross margin 2023: € 4,552,354 ▲ 4% vs 2022 (€ 4,374,247) Favourable step	€ 4,773,168 Gross margin 2024: € 4,773,168 ▲ 5% vs 2023 (€ 4,552,354) Favourable step	€ 4,960,704 Gross margin 2025: € 4,960,704 ▲ 4% vs 2024 (€ 4,773,168) Favourable step	▲ 4%
Profit after taxes	€ 77,053 Profit after taxes 2022: € 77,053 First fiscal year in the series	€ 97,295 Profit after taxes 2023: € 97,295 ▲ 26% vs 2022 (€ 77,053) Favourable step	€ 168,214 Profit after taxes 2024: € 168,214 ▲ 73% vs 2023 (€ 97,295) Favourable step	€ 249,972 Profit after taxes 2025: € 249,972 ▲ 49% vs 2024 (€ 168,214) Favourable step	▲ 49%
Equity	€ 3,391,285 Equity 2022: € 3,391,285 First fiscal year in the series	€ 3,474,804 Equity 2023: € 3,474,804 ▲ 2% vs 2022 (€ 3,391,285) Favourable step	€ 3,629,242 Equity 2024: € 3,629,242 ▲ 4% vs 2023 (€ 3,474,804) Favourable step	€ 3,871,969 Equity 2025: € 3,871,969 ▲ 7% vs 2024 (€ 3,629,242) Favourable step	▲ 7%
Total debts	€ 4,819,911 Total debts 2022: € 4,819,911 First fiscal year in the series	€ 4,730,243 Total debts 2023: € 4,730,243 ▼ 2% vs 2022 (€ 4,819,911) Favourable step	€ 3,788,470 Total debts 2024: € 3,788,470 ▼ 20% vs 2023 (€ 4,730,243) Favourable step	€ 3,705,448 Total debts 2025: € 3,705,448 ▼ 2% vs 2024 (€ 3,788,470) Favourable step	▼ 2%
Cash	€ 3,311,558 Cash 2022: € 3,311,558 First fiscal year in the series	€ 2,964,525 Cash 2023: € 2,964,525 ▼ 10% vs 2022 (€ 3,311,558) Unfavourable step	€ 1,505,443 Cash 2024: € 1,505,443 ▼ 49% vs 2023 (€ 2,964,525) Unfavourable step	€ 2,000,049 Cash 2025: € 2,000,049 ▲ 33% vs 2024 (€ 1,505,443) Favourable step	▲ 33%
Land & buildings	€ 3,937,988 Land & buildings 2022: € 3,937,988 First fiscal year in the series	€ 3,767,556 Land & buildings 2023: € 3,767,556 ▼ 4% vs 2022 (€ 3,937,988) Unchanged	€ 3,688,876 Land & buildings 2024: € 3,688,876 ▼ 2% vs 2023 (€ 3,767,556) Unchanged	€ 3,513,709 Land & buildings 2025: € 3,513,709 ▼ 5% vs 2024 (€ 3,688,876) Unchanged	▼ 5%
Retained profit	€ 3,205,274 Retained profit 2022: € 3,205,274 First fiscal year in the series	€ 3,302,569 Retained profit 2023: € 3,302,569 ▲ 3% vs 2022 (€ 3,205,274) Favourable step	€ 3,470,782 Retained profit 2024: € 3,470,782 ▲ 5% vs 2023 (€ 3,302,569) Favourable step	€ 3,720,754 Retained profit 2025: € 3,720,754 ▲ 7% vs 2024 (€ 3,470,782) Favourable step	▲ 7%
Bank debt	€ 3,241,103 Bank debt 2022: € 3,241,103 First fiscal year in the series	€ 3,141,016 Bank debt 2023: € 3,141,016 ▼ 3% vs 2022 (€ 3,241,103) Favourable step	€ 3,036,244 Bank debt 2024: € 3,036,244 ▼ 3% vs 2023 (€ 3,141,016) Favourable step	€ 2,926,567 Bank debt 2025: € 2,926,567 ▼ 4% vs 2024 (€ 3,036,244) Favourable step	▼ 4%
Balance sheet total	€ 8,211,196 Balance sheet total 2022: € 8,211,196 First fiscal year in the series	€ 8,205,048 Balance sheet total 2023: € 8,205,048 Unchanged (€ 8,211,196) Unchanged	€ 7,417,712 Balance sheet total 2024: € 7,417,712 ▼ 10% vs 2023 (€ 8,205,048) Unchanged	€ 7,577,418 Balance sheet total 2025: € 7,577,418 ▲ 2% vs 2024 (€ 7,417,712) Unchanged	▲ 2%
Employees (FTE)	48.7 Employees (FTE) 2022: 48.7 First fiscal year in the series	47.4 Employees (FTE) 2023: 47.4 ▼ 1.3 vs 2022 (48.7) Unchanged	48.4 Employees (FTE) 2024: 48.4 ▲ 1 vs 2023 (47.4) Unchanged	48.5 Employees (FTE) 2025: 48.5 ▲ 0.1 vs 2024 (48.4) Unchanged	▲ 0.1

Key figures of ANTWERPS DRUG INTERVENTIE CENTRUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ANTWERPS DRUG INTERVENTIE CENTRUM?

What happened at ANTWERPS DRUG INTERVENTIE CENTRUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 7, 2026 New annual accounts for financial year 2025: profit of € 249,972 (▲ 49% vs 2024). Source: NBB ↗
Jun 14, 2006 New establishment in Antwerpen. KBO
Oct 7, 1985 Start of the company according to the CBE. KBO

In short

From € 77,053 profit in 2022 to € 249,972 profit in 2025.

Best year ever: 2025, with € 249,972 profit.

On average € 102,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Alain Florquin Stefaan Voet Jimmy Schevernels Jan De Maeyer +1

CHRISTELIJKE SOCIALE WERKEN REGIO MECHELEN-TURNHOUT

Bestuur der Katholieke Maatschappelijke Werken voor het Arrondissement Antwerpen

ANTWERPS DRUG INTERVENTIE CENTRUM

MAISON DE LA SOLIDARITE

+17

Behind ANTWERPS DRUG INTERVENTIE CENTRUM are Alain Florquin, Stefaan Voet, Jimmy Schevernels, Jan De Maeyer and Robby Cardinas. Stefaan Voet is also behind CHRISTELIJKE SOCIALE WERKEN REGIO MECHELEN-TURNHOUT, Bestuur der Katholieke Maatschappelijke Werken voor het Arrondissement Antwerpen, Participo CM Antwerpen, Volksverheffing and Emmaüs. Jimmy Schevernels is also behind MAISON DE LA SOLIDARITE, i-mens Thuishulp, i-mens, Zelfstandige Thuisverpleging i-mens and Vlaams Socialistisch Gezondheidsfonds.

Directors

According to the 2025 annual accounts

Alain Florquin

Managing director

Stefaan Voet

Director

Also active at: CHRISTELIJKE SOCIALE WERKEN REGIO MECHELEN-TURNHOUT, Bestuur der Katholieke Maatschappelijke Werken voor het Arrondissement Antwerpen, Participo CM Antwerpen, Volksverheffing, Emmaüs, Kristelijke Medico - Sociale Instellingen, IMSOL, PULDERBOS REVALIDATIECENTRUM VOOR KINDEREN EN JONGEREN

Jimmy Schevernels

Chairman of the board

Also active at: MAISON DE LA SOLIDARITE, i-mens Thuishulp, i-mens, Zelfstandige Thuisverpleging i-mens, Vlaams Socialistisch Gezondheidsfonds, i-mens Thuisverpleging, Vrijwilligerswerk i-mens, De Sloep i-mens +4 more

Jan De Maeyer

Director

Robby Cardinas

Director

Also active at: Parcifal Consulting

Establishments

Establishment units

Physical locations of this company

Registered office

Venusstraat 11

2000 Antwerpen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0431.752.146

VAT number

BE 0431.752.146

Registered office

Venusstraat 11, 2000 Antwerpen

Names & denominations

ANTWERPS DRUG INTERVENTIE CENTRUM · ADIC

Enterprise type

Rechtspersoon

Legal form

Non-profit association

Legal situation

Normale toestand

Start date

7 October 1985

Peppol

Active · Active since 21 Oct 2026

Activities · NACE

Activiteiten van gespecialiseerde ziekenhuizen

Ziekenhuizen

View on CBE Public ↗ Annual accounts (NBB) ↗

ANTWERPS DRUG INTERVENTIE CENTRUM

Financials

What happened to ANTWERPS DRUG INTERVENTIE CENTRUM?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions